beyond spring pharma stock

BeyondSpring now will take its case to the. Learn More About Our Differentiated RD Strategy.

Beyondspring News Today Why Did Beyondspring Go Down Today Nasdaq Bysi

Is a global biopharmaceutical company that is focused on developing immuno-oncology cancer therapies.

. It had slid 27 in the six months through Tuesday. 1 We own global rights to plinabulin in all countries except China. The stock recently traded at 2711 compared with its Tuesday close at 963.

Events presentations. According to the issued ratings of 6 analysts in the last year the consensus rating for BeyondSpring stock is Hold based on the current 1 sell rating 3 hold ratings and 2 buy. BeyondSpring Inc a clinical stage biopharmaceutical company together with its subsidiaries focuses on the development and commercialization of immuno-oncology cancer.

BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update. Ad Horizon Is A Leading High-Growth Biopharma Company. Get the latest BeyondSpring Inc.

In China we own a 5797 interest in our. Lan Huang Beyond Springs co-founder chairman and chief executive officer. Find real-time BYSI - Beyondspring Inc stock quotes company profile news and forecasts from CNN Business.

Discover our most recent and upcoming events as well as download informative presentationsall right here. Ramon Mohanlal MD PhD. They recently received or are about to receive 30mn.

BYSI stock quote history news and other vital information to help you with your stock trading and investing. Companies this small are. Real-time last sale data for US.

BeyondSpring is a noticeably small company with a market capitalisation of US392m. Shares of BeyondSpring BYSI -237 a clinical-stage biotech company have been surging this week in response to a lucrative new partnership with Jiangsu Hengrui. Intraday data delayed at least 15 minutes or per exchange.

BYSI now has a market cap of 132mn a cash reserve of 93mn a small debt of 45mn and a large short interest of 23. BYSI stock price quote stock graph news analysis. Learn More About Our Differentiated RD Strategy.

All quotes are in local exchange time. BeyondSpring is a global clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from. Processa Pharmaceuticals has a consensus price target of.

BYSI stock news and headlines to help you in your trading and investing decisions. Stock quotes reflect trades reported through Nasdaq only. The service offers end-to-end research on both investing and trading ideas everyday and includes a 150-stock watchlist and two 40-stock model portfolios that are.

Up from US1175 the current price target is an average from 4 analysts. Real time BeyondSpring Inc. New target price is 462 above last closing price of US243.

Ad Horizon Is A Leading High-Growth Biopharma Company. Most companies this size are not always actively traded. - Company to host call today April 14 2022 at 800 am ET -.

Price target increased to US1367. Global pharmaceutical company BeyondSpring announced positive findings in a late-stage trial of a drug combo to treat second- and third-line nonsmall cell lung cancer. Beyond Springs co-founder chairman and.

BYSI stock are taking off on Wednesday following an important update regarding the firms lung cancer treatment. Shares of BeyondSpring BYSI 372 soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational lung. Clinical stage biopharma companies BeyondSpring BYSI and CTI BioPharma CTIC have gained 49 and 45 in the pre-market respectively on below-average volume.

Find the latest BeyondSpring Inc. Shares of BeyondSpring NASDAQ.

Circling Back On Beyondspring Bysi Stock Seeking Alpha